Literature DB >> 31104772

The Genomic Medicine Integrative Research Framework: A Conceptual Framework for Conducting Genomic Medicine Research.

Carol R Horowitz1, Lori A Orlando2, Anne M Slavotinek3, Josh Peterson4, Frank Angelo5, Barbara Biesecker6, Vence L Bonham7, Linda D Cameron8, Stephanie M Fullerton9, Bruce D Gelb10, Katrina A B Goddard8, Benyam Hailu11, Ragan Hart5, Lucia A Hindorff12, Gail P Jarvik5, Dave Kaufman13, Eimear E Kenny14, Sara J Knight15, Barbara A Koenig16, Bruce R Korf17, Ebony Madden12, Amy L McGuire18, Jeffrey Ou5, Melissa P Wasserstein19, Mimsie Robinson20, Howard Leventhal21, Saskia C Sanderson22.   

Abstract

Conceptual frameworks are useful in research because they can highlight priority research domains, inform decisions about interventions, identify outcomes and factors to measure, and display how factors might relate to each other to generate and test hypotheses. Discovery, translational, and implementation research are all critical to the overall mission of genomic medicine and prevention, but they have yet to be organized into a unified conceptual framework. To fill this gap, our diverse team collaborated to develop the Genomic Medicine Integrative Research (GMIR) Framework, a simple but comprehensive tool to aid the genomics community in developing research questions, strategies, and measures and in integrating genomic medicine and prevention into clinical practice. Here we present the GMIR Framework and its development, along with examples of its use for research development, demonstrating how we applied it to select and harmonize measures for use across diverse genomic medicine implementation projects. Researchers can utilize the GMIR Framework for their own research, collaborative investigations, and clinical implementation efforts; clinicians can use it to establish and evaluate programs; and all stakeholders can use it to help allocate resources and make sure that the full complexity of etiology is included in research and program design, development, and evaluation.
Copyright © 2019 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  conceptual; diversity; framework; genomics; implementation; model; translational research

Mesh:

Year:  2019        PMID: 31104772      PMCID: PMC6556906          DOI: 10.1016/j.ajhg.2019.04.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

2.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

Review 3.  Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.

Authors:  Courtney L Scherr; Elsa Vasquez; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Rev Recent Clin Trials       Date:  2014

4.  Attitudes of African Americans toward return of results from exome and whole genome sequencing.

Authors:  Joon-Ho Yu; Julia Crouch; Seema M Jamal; Holly K Tabor; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2013-05       Impact factor: 2.802

5.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

6.  Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

Authors:  J M Pulley; J C Denny; J F Peterson; G R Bernard; C L Vnencak-Jones; A H Ramirez; J T Delaney; E Bowton; K Brothers; K Johnson; D C Crawford; J Schildcrout; D R Masys; H H Dilks; R A Wilke; E W Clayton; E Shultz; M Laposata; J McPherson; J N Jirjis; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2012-05-16       Impact factor: 6.875

7.  Electronic health record design and implementation for pharmacogenomics: a local perspective.

Authors:  Josh F Peterson; Erica Bowton; Julie R Field; Marc Beller; Jennifer Mitchell; Jonathan Schildcrout; William Gregg; Kevin Johnson; Jim N Jirjis; Dan M Roden; Jill M Pulley; Josh C Denny
Journal:  Genet Med       Date:  2013-09-05       Impact factor: 8.822

8.  The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study.

Authors:  Tara C Matise; Jose Luis Ambite; Steven Buyske; Christopher S Carlson; Shelley A Cole; Dana C Crawford; Christopher A Haiman; Gerardo Heiss; Charles Kooperberg; Loic Le Marchand; Teri A Manolio; Kari E North; Ulrike Peters; Marylyn D Ritchie; Lucia A Hindorff; Jonathan L Haines
Journal:  Am J Epidemiol       Date:  2011-08-11       Impact factor: 4.897

Review 9.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future.

Authors:  Omri Gottesman; Helena Kuivaniemi; Gerard Tromp; W Andrew Faucett; Rongling Li; Teri A Manolio; Saskia C Sanderson; Joseph Kannry; Randi Zinberg; Melissa A Basford; Murray Brilliant; David J Carey; Rex L Chisholm; Christopher G Chute; John J Connolly; David Crosslin; Joshua C Denny; Carlos J Gallego; Jonathan L Haines; Hakon Hakonarson; John Harley; Gail P Jarvik; Isaac Kohane; Iftikhar J Kullo; Eric B Larson; Catherine McCarty; Marylyn D Ritchie; Dan M Roden; Maureen E Smith; Erwin P Böttinger; Marc S Williams
Journal:  Genet Med       Date:  2013-06-06       Impact factor: 8.822

10.  Attitudes of clinicians following large-scale pharmacogenomics implementation.

Authors:  J F Peterson; J R Field; Y Shi; J S Schildcrout; J C Denny; T L McGregor; S L Van Driest; J M Pulley; I M Lubin; M Laposata; D M Roden; E W Clayton
Journal:  Pharmacogenomics J       Date:  2015-08-11       Impact factor: 3.550

View more
  14 in total

Review 1.  Conceptualization of utility in translational clinical genomics research.

Authors:  Hadley Stevens Smith; Kyle B Brothers; Sara J Knight; Sara L Ackerman; Christine Rini; David L Veenstra; Amy L McGuire; Benjamin S Wilfond; Janet Malek
Journal:  Am J Hum Genet       Date:  2021-10-22       Impact factor: 11.025

Review 2.  Perceived Utility of Genomic Sequencing: Qualitative Analysis and Synthesis of a Conceptual Model to Inform Patient-Centered Instrument Development.

Authors:  Hadley Stevens Smith; Stephanie R Morain; Jill Oliver Robinson; Isabel Canfield; Janet Malek; Caryn Kseniya Rubanovich; Cinnamon S Bloss; Sara L Ackerman; Barbara Biesecker; Kyle B Brothers; Crispin N Goytia; Carol R Horowitz; Sara J Knight; Barbara Koenig; Stephanie A Kraft; Simon Outram; Christine Rini; Kelly J Shipman; Margaret Waltz; Benjamin Wilfond; Amy L McGuire
Journal:  Patient       Date:  2021-10-18       Impact factor: 3.481

3.  Distribution of Genomic Testing Resources by Oncology Practice and Rurality: A Nationally Representative Study.

Authors:  Brittany Gardner; Michelle Doose; Janeth I Sanchez; Andrew N Freedman; Janet S de Moor
Journal:  JCO Precis Oncol       Date:  2021-06-22

4.  The AutGO Initiative: A Conceptual Framework for Developing Genetics-Outcomes Research Hypotheses.

Authors:  Zohreh Talebizadeh; Ayten Shah
Journal:  Autism Res       Date:  2020-07-03       Impact factor: 5.216

5.  Lessons learned about harmonizing survey measures for the CSER consortium.

Authors:  Katrina A B Goddard; Frank A N Angelo; Sara L Ackerman; Jonathan S Berg; Barbara B Biesecker; Maria I Danila; Kelly M East; Lucia A Hindorff; Carol R Horowitz; Jessica Ezzell Hunter; Galen Joseph; Sara J Knight; Amy McGuire; Kristin R Muessig; Jeffrey Ou; Simon Outram; Elizabeth J Rahn; Michelle A Ramos; Christine Rini; Jill O Robinson; Hadley Stevens Smith; Margaret Waltz; Sandra Soo-Jin Lee
Journal:  J Clin Transl Sci       Date:  2020-04-24

6.  Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.

Authors:  Kelsey S Lau-Min; Lisa A Varughese; Maria N Nelson; Christine Cambareri; Nandi J Reddy; Randall A Oyer; Ursina R Teitelbaum; Sony Tuteja
Journal:  BMC Cancer       Date:  2022-01-08       Impact factor: 4.638

7.  Practices and Attitudes toward Returning Genomic Research Results to Low-Resource Research Participants.

Authors:  Megan B Raymond; Kayla E Cooper; Lisa S Parker; Vence L Bonham
Journal:  Public Health Genomics       Date:  2021-07-06       Impact factor: 2.132

8.  Ensuring Best Practice in Genomic Education and Evaluation: A Program Logic Approach.

Authors:  Amy Nisselle; Melissa Martyn; Helen Jordan; Nadia Kaunein; Alison McEwen; Chirag Patel; Bronwyn Terrill; Michelle Bishop; Sylvia Metcalfe; Clara Gaff
Journal:  Front Genet       Date:  2019-11-08       Impact factor: 4.599

9.  Evaluating Research Centers in Minority Institutions: Framework, Metrics, Best Practices, and Challenges.

Authors:  Angela Sy; Traci Hayes; Kelly Laurila; Carlamarie Noboa; Robbert J Langwerden; Michelle M Hospital; Doris A Andújar-Pérez; Lakesha Stevenson; Suzanne M Randolph Cunningham; Latrice Rollins; Hala Madanat; Tanya Penn; Shiva Mehravaran
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

10.  Engaging community stakeholders in research on best practices for clinical genomic sequencing.

Authors:  Ida Griesemer; Brooke S Staley; Alexandra F Lightfoot; Lizzy Bain; Derrick Byrd; Carol Conway; Tracey L Grant; Barbara Leach; Laura Milko; Lonna Mollison; Nadiah Porter; Sharron Reid; Gerri Smith; Margaret Waltz; Jonathan S Berg; Christine Rini; Julianne M O'Daniel
Journal:  Per Med       Date:  2020-10-07       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.